Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
Vasculitis
How do you approach treatment of livido vasculitis?
Does your treatment change if there are open ulcers?
Related Questions
How do you approach confirming a diagnosis of limited GPA with nasal involvement vs relapsing polychondritis?
What would be your approach to managing severe ANCA-associated vasculitis in a patient who is also septic from a bacterial infection?
How would you approach the evaluation and management of isolated vasculitis with aneurysms involving the segmental hepatic arteries causing hepatic hemorrhage in an otherwise healthy patient in his 80s?
Do you always pursue biopsy confirmation before diagnosing IgA vasculitis?
Do you continue PJP prophylaxis indefinitely in patients on rituximab maintenance therapy?
How would you approach the workup of a female patient who has recurrent sinusitis with polyps (biopsy showed active and chronic inflammation) and myocarditis, but negative ANCA and normal eosinophil counts?
How do you differentiate fibromuscular dysplasia from PAN / abdominal vasculitis?
How would you approach a patient with EGPA, with main manifestations of asthma, nasal polyposis, and mononeuritis multiplex, who has clinically responded to rituximab, yet has persistently high eosinophilia (>40%)?
Would you consider anti-IL-5 therapy (mepolizumab or benralizumab) to either prevent or treat the more severe manifestations of eosinophilic granulomatosis with polyangiitis, such as "infiltrative" (eg cardiomyopathy, pulmonary infiltrates, or gastroenteritis) or "vasculitic" (eg neuropathy, palpable purpura, or glomerulonephritis)?
How do you approach worsening memory loss in patients with GCA?